Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Holst

Showing results (111-120 of 1,570) with videos related to

Pageof 157
Sort By:
Acta Physiologica Scandinavica|August 1, 1997
Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humansH Larsson, J J Holst, B Ahrén
Scandinavian Journal of Gastroenterology|January 1, 1976
The enteroglucagon response to intrajejunal infusion of glucose, triglycerides, and sodium chloride, and its relation to jejunal inhibition of gastric acid secretion in manJ J Holst, J Christiansen, C Kühl
Acta Physiologica Scandinavica|December 1, 1982
Effects of adrenergic blockade on the release of insulin, glucagon and somatostatin from the pancreas in response to splanchnic nerve stimulation in catsP O Andersson, J Holst, J Järhult
The Journal of Clinical Endocrinology and Metabolism|February 1, 1992
All products of proglucagon are elevated in plasma from uremic patientsC Orskov, J Andreasen, J J Holst
Acta Diabetologica|July 16, 2011
Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collectionE Ekholm, N Shaat, J J Holst
European Journal of Endocrinology|August 1, 1997
Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose toleranceB Ahrén, H Larsson, J J Holst
Trends in Molecular Medicine|November 16, 2017
TRPV1: A Potential Therapeutic Target in Type 2 Diabetes and Comorbidities?Dorte X Gram, Jens J Holst, Arpad Szallasi
Diabetologia|February 1, 2006
Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigsL Simonsen, J J Holst, C F Deacon
Acta Chirurgica Scandinavica|January 1, 1977
Influence of different techniques of proximal gastric vagotomy upon risk of recurrent duodenal ulcer and gastric acid secretionO Kronborg, P M Jorgensen, J Holst-Christensen
Expert Opinion on Investigational Drugs|August 28, 2004
Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?Carolyn F Deacon, Bo Ahrén, Jens J Holst
Pageof 157

Showing results (111-120 of 1,570) with videos related to

Sort By:
Pageof 157
Acta Physiologica Scandinavica|August 1, 1997
Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humansH Larsson, J J Holst, B Ahrén
Scandinavian Journal of Gastroenterology|January 1, 1976
The enteroglucagon response to intrajejunal infusion of glucose, triglycerides, and sodium chloride, and its relation to jejunal inhibition of gastric acid secretion in manJ J Holst, J Christiansen, C Kühl
Acta Physiologica Scandinavica|December 1, 1982
Effects of adrenergic blockade on the release of insulin, glucagon and somatostatin from the pancreas in response to splanchnic nerve stimulation in catsP O Andersson, J Holst, J Järhult
The Journal of Clinical Endocrinology and Metabolism|February 1, 1992
All products of proglucagon are elevated in plasma from uremic patientsC Orskov, J Andreasen, J J Holst
Acta Diabetologica|July 16, 2011
Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collectionE Ekholm, N Shaat, J J Holst
European Journal of Endocrinology|August 1, 1997
Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose toleranceB Ahrén, H Larsson, J J Holst
Trends in Molecular Medicine|November 16, 2017
TRPV1: A Potential Therapeutic Target in Type 2 Diabetes and Comorbidities?Dorte X Gram, Jens J Holst, Arpad Szallasi
Diabetologia|February 1, 2006
Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigsL Simonsen, J J Holst, C F Deacon
Acta Chirurgica Scandinavica|January 1, 1977
Influence of different techniques of proximal gastric vagotomy upon risk of recurrent duodenal ulcer and gastric acid secretionO Kronborg, P M Jorgensen, J Holst-Christensen
Expert Opinion on Investigational Drugs|August 28, 2004
Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?Carolyn F Deacon, Bo Ahrén, Jens J Holst
Pageof 157